[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-340352-105":59,"doc-detail-340352-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","fbln2-is-associated-with-basal-cell-markers-krt14-and-itgb1-in-mouse-mammary-epithelial-cells-and-has-a-preferential-expression-in-molecular-subtypes-of-human-breast-cancer","FBLN2 is associated with basal cell markers Krt14 and ITGB1 in mouse mammary epithelial cells and has a preferential expression in molecular subtypes of human breast cancer","","Fibulin-2 (FBLN2) is a secreted extracellular matrix glycoprotein implicated in mammary development and cancer progression. The study examined whether FBLN2 supports a myoepithelial phenotype in mammary epithelium and evaluated FBLN2 expression across molecular subtypes of human breast cancer. Pubertal mouse tissue and EpH4 cells were analyzed for epithelial-marker relationships, while METABRIC and TCGA mRNA datasets were used for subtype association and prognosis assessment.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/fbln2-is-associated-with-basal-cell-markers-krt14-and-itgb1-in-mouse-mammary-epithelial-cells-and-has-a-preferential-expression-in-molecular-subtypes-of-human-breast-cancer/340352/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/fbln2-is-associated-with-basal-cell-markers-krt14-and-itgb1-in-mouse-mammary-epithelial-cells-and-has-a-preferential-expression-in-molecular-subtypes-of-human-breast-cancer/340352.png","ImageObject",300,407,{"name":92,"@type":93},"Eden","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is Fibulin-2 (FBLN2) and why was it studied in breast cancer?","Question",{"text":112,"@type":113},"FBLN2 is a secreted extracellular matrix glycoprotein linked to basement membrane integrity in mammary epithelium. Its loss has been associated with human breast cancer invasion, motivating evaluation of its role in epithelial phenotype and cancer subtypes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the relationship between FBLN2 and epithelial markers investigated?",{"text":117,"@type":113},"Mouse pubertal mammary glands and EpH4 mammary epithelial cells were examined using immunohistochemistry, immunocytochemistry, and immunoblotting. Human breast cancer mRNA data from METABRIC and TCGA were then analyzed to test associations with epithelial markers and molecular subtypes.",{"name":119,"@type":110,"acceptedAnswer":120},"What did FBLN2 knockdown and TGFβ3 treatment show in mouse epithelial cells?",{"text":121,"@type":113},"FBLN2 knockdown reduced KRT14 (KRT14) and increased KRT18. Treatment with TGFβ3 upregulated FBLN2 in vitro.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},340352,1790193923,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374391974468,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Breast Cancer Research and Treatment (2024) 208:673–686  \n[https://doi.org/10.1007/s10549-024-07447-y](https://doi.org/10.1007/s10549-024-07447-y)  \nFBLN2 is associated with basal cell markers Krt14 and ITGB1 in mouse mammary epithelial cells and has a preferential expression in molecular subtypes of human breast cancer  \nAmr Ahmed WalyEldeen1 · Salwa Sabet1 · Shady E. Anis2 · Torsten Stein3,4 · Ayman M. Ibrahim1,5  \nReceived: 5 April 2024 / Accepted: 24 July 2024 / Published online: 7 August 2024 © The Author(s) 2024, corrected publication 2024  \nAbstract  \nBackground Fibulin-2 (FBLN2) is a secreted extracellular matrix (ECM) glycoprotein and has been identified in the mouse mammary gland, in cap cells of terminal end buds (TEBs) during puberty, and around myoepithelial cells during early pregnancy. It is required for basement membrane (BM) integrity in mammary epithelium, and its loss has been associated with human breast cancer invasion. Herein, we attempted to confirm the relevance ofFBLN2 to myoepithelial phenotype in mammary epithelium and to assess its expression in molecular subtypes of human breast cancer.  \nMethods The relationship between FBLN2 expression and epithelial markers was investigated in pubertal mouse mammary glands and the EpH4 mouse mammary epithelial cell line using immunohistochemistry, immunocytochemistry, and immunoblotting. Human breast cancer mRNA data from the METABRIC and TCGA datasets from Bioportal were analyzed to assess the association of Fbln2 expression with epithelial markers, and with molecular subtypes. Survival curves were generated using data from the METABRIC dataset and the KM databases.  \nResults FBLN2 knockdown in mouse mammary epithelial cells was associated with a reduction in KRT14 and an increase in KRT18. Further, TGFβ3 treatment resulted in the upregulation ofFBLN2 in vitro. Meta-analyses of human breast cancer datasets from Bioportal showed a higher expression ofFbln2 mRNA in claudin-low, LumA, and normal-like breast cancers compared to LumB, Her2 +, and Basal-like subgroups. Fbln2 mRNA levels were positively associated with mesenchymal markers, myoepithelial markers, and markers of epithelial–mesenchymal transition. Higher expression of Fbln2 mRNA was associated with better prognosis in less advanced breast cancer and this pattern was reversed in more advanced lesions. Conclusion With further validation, these observations may offer a molecular prognostic tool for human breast cancer for more personalized therapeutic approaches.  \nKeywords Fibulin-2 · ECM · Basal · Breast cancer · Molecular subtypes  \n* Ayman M. Ibrahim [sci_ayman@cu.edu.eg](sci_ayman@cu.edu.eg)  \n1 Department of Zoology, Faculty of Science, Cairo University, Giza 12613, Egypt  \n2 Department of Pathology, Faculty of Medicine, Cairo University, Cairo 11562, Egypt  \n3 Institute of Veterinary Biochemistry, Freie Universität Berlin, 14163 Berlin, Germany  \n4 Institute of Cancer Sciences, College of MVLS, University of Glasgow, Glasgow G12 8QQ, UK  \n5 Aswan Heart Centre, Magdi Yacoub Heart Foundation, Aswan, Egypt  \nIntroduction  \nBreast cancer is the most prevalent type of cancer and the leading cause of mortality among women worldwide [1, 2] . The complexity and heterogeneity of breast cancer make it challenging to accurately describe the causing factors that simultaneously promote cancer cells, and disease progression and eventually predict patient’s prognosis [3] . While almost all breast cancers arise in the breast’s ductal lobular units, cancer cells are enclosed within a complex microenvironment of stromal cells, including immune cells, fibroblasts, and adipocytes, all embedded in an ECM that is produced and interact with stromal cells [4–7] .  \nIn physiological conditions, ECM is required to maintain tissue homeostasis in conjunction with various cell  \ncomponents in response to cell–cell and cell–ECM interaction [8] . ECM remodeling associated with cancer development occurs via the breakup of old ECM p","cbCaiavQ3PsfUJcJ","https://ap.wps.com/l/cbCaiavQ3PsfUJcJ","pdf",2529692,14,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction\n# Materials and methods\n## Animal husbandry and mammary gland tissue processing","[{\"question\":\"What is Fibulin-2 (FBLN2) and why was it studied in breast cancer?\",\"answer\":\"FBLN2 is a secreted extracellular matrix glycoprotein linked to basement membrane integrity in mammary epithelium. Its loss has been associated with human breast cancer invasion, motivating evaluation of its role in epithelial phenotype and cancer subtypes.\"},{\"question\":\"How was the relationship between FBLN2 and epithelial markers investigated?\",\"answer\":\"Mouse pubertal mammary glands and EpH4 mammary epithelial cells were examined using immunohistochemistry, immunocytochemistry, and immunoblotting. Human breast cancer mRNA data from METABRIC and TCGA were then analyzed to test associations with epithelial markers and molecular subtypes.\"},{\"question\":\"What did FBLN2 knockdown and TGFβ3 treatment show in mouse epithelial cells?\",\"answer\":\"FBLN2 knockdown reduced KRT14 (KRT14) and increased KRT18. Treatment with TGFβ3 upregulated FBLN2 in vitro.\"}]","FBLN2 is associated with basal cell markers Krt14 and ITGB1 in mouse mammary epithelial cells and has a preferential expression in molecular subtypes of human breast cancer | PDF",1790035966,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fd04eb7f7286612e2fb5562fe3cc536b.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/02bd6a9610c41a18d3f94fe863c85b4c.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/db260cc0d5cb668281664788a36c8b31.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ac8f6e4712bffb917f143c8ff003ac6f.webp",980,1301]